Device Trial Radar · NCT06557434
AV-23-001 AVAVA MIRIA Pilot Study
Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
10
Actual
Start
Nov 6, 2023
Primary completion
Jul 3, 2024
Study completion Jul 3, 2024
Sponsor
- Lead sponsor
- AVAVA, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 16, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This non-significant risk study is intended to demonstrate the use of the MIRIA Skin Treatment System can show improvement in dermatologic conditions currently indicated for treatment with a laser (such as, but not limited to, benign pigmented lesions, benign cutaneous lesions, wrinkles, textural irregularities, or scars). The study is also intended to assist in determination of the optimal laser configuration and treatment parameters that most consistently yield results.
Conditions
- Wrinkle
- Acne Scars - Mixed Atrophic and Hypertrophic
- Pigmented Lesions
- Skin Laxity
- Scars
Interventions
MIRIADevice
The MIRIA Skin Treatment System is a 1550nm-based laser system indicated for use in dermatologic procedures requiring the coagulation of soft tissue, as well as for skin resurfacing procedures.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Global Aesthetic Improvement Scale (GAIS)Time frame: 3 Months
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Skinfluence Long Island
Dix Hills, New York
Laser and Skin Surgery Center of New York
New York, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.